MASTER AGREEMENT FOR CLINICAL RESEARCH SERVICESMaster Agreement for Clinical Research Services • March 9th, 2010 • Idenix Pharmaceuticals Inc • Pharmaceutical preparations • Massachusetts
This MASTER AGREEMENT FOR CLINICAL RESEARCH SERVICES (this “Agreement”) is made effective January 30, 2009 (the “Effective Date”) by and between Idenix Pharmaceuticals, Inc., a Delaware corporation having a current address of 60 Hampshire Street, Cambridge, MA 02139 USA, (“Company”), and ACLIRES International, Ltd, a Bermudian Company, based at Milner House, 18 Parliament Street, Hamilton HM FX, Bermuda (“CRO”). Company and CRO may be referred to herein each, individually, as a “Party” or, collectively, as the “Parties”.
